New SEC Form D filing

Simbryo Technologies, Inc., 2026-07-27

A new SEC Form D private-offering notice from Houston, TX, a $5,252,615 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Simbryo Technologies, Inc. site↗ Verified via SEC Form D

Develops organoid based diagnostics that use a patient's own stem cells to test endometrial fertility and predict IVF implantation success

Filed 2026-07-27Filed to raise $5,252,615First money in 2025-09-26Raised so far $5,250,972HQ (as filed) Houston, TXSector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified simbryotech.com↗Named in the filing 4 executives & directors
Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source